Skip to main content
. Author manuscript; available in PMC: 2013 Dec 15.
Published in final edited form as: Cancer. 2012 Jun 6;118(24):6188–6198. doi: 10.1002/cncr.27653

Table 2.

Demographic and clinical variables for CRC patients

Variables Training Set (N=435)
Replication Set (N=227)
Recurrence No recurrence P Value Dead Alive P value Recurrence No recurrence P value Dead Alive P value
Age, mean (SD) 59.2 (13.7) 58.4 (12.8) 0.6 62.3(13.3) 57.9 (12.8) 0.01 57.06(12.30) 53.00(16.28) 0.23 56.77(12.26) 56.86(13.00) 0.95
Smoking pack-years (SD) 37.4(36.9) 30.8(39.3) 0.33 37.2 (36.4) 31.4(39.2) 0.47 27.30(20.74) 22.70(15.12) 0.63 25.30(21.68) 30.20(21.05) 0.29
Gender, N (%)
 Male 57(61.3) 206(60.2) 41(63.1) 222(60.0) 124(58.8) 7(46.7) 72(58.1) 60(58.3)
 Female 36(38.7) 136(39.8) 0.85 24(36.9) 148(40.0) 0.64 87(41.2) 8(53.3) 0.36 52(41.9) 43(41.7) 0.98
Race, N (%)
 Caucasian 73(78.5) 279(81.8) 51(78.5) 301(81.6) 179(84.8) 12(80.0) 105(84.7) 87(84.5)
 African-American 9(9.7) 33(9.7) 7(10.8) 35(9.5) 11(5.2) 1(6.7) 7(5.6) 5(4.9)
 Others 11(11.8) 29(8.5) 0.61 7(10.8) 33(8.9) 0.84 21(10.0) 2(13.3) 0.88 12(9.7) 11(10.7) 0.94
Tumor location, N (%)
 Proximal 21(23.3) 100(29.4) 14(22.6) 107(29.1) 64(32.0) 3(20.0) 40(35.1) 27(26.5)
 Distal 20(22.2) 80(23.5) 17(27.4) 83(22.6) 70(35.0) 8(53.3) 40(35.1) 39(38.2)
 Rectal 49(54.4) 160(47.1) 0.41 31(50.0) 178(48.4) 0.51 66(33.0) 4(26.7) 0.35 34(29.8) 36(35.3) 0.38
Stage, N (%)
 Stage I 4(4.3) 57(16.7) 2(3.1) 59(15.9) 27(12.8) 0(0.0) 15(12.1) 12(11.7)
 Stage II 36(38.7) 135(39.5) 26(40.0) 145(39.2) 78(37.0) 9(60.0) 43(34.7) 45(43.7)
 Stage III 53(57.0) 150(43.9) 0.005 37(56.9) 166(44.9) 0.02 106(50.2) 6(40.0) 0.13 66(53.2) 46(44.7) 0.36
Histology grade, N (%)
 Well-differentiated 4(4.4) 11(3.3) 3(4.8) 12(3.3) 8(3.9) 0(0.0) 5(4.2) 3(3.0)
 Moderate-differentiated 73(80.2) 283(84.2) 49(77.8) 307(84.3) 159(77.9) 11(78.6) 88(74.6) 83(82.2)
 Poorly-differentiated 14(15.4) 42(12.5) 0.65 11(17.5) 45(12.4) 0.43 37(18.1) 3(21.4) 0.73 25(21.2) 15(14.9) 0.40